It’s broadly comparable for any drug.
You start with a promising drug compound. You test it in cell cultures, mouse and/or other animal studies; this gives a decent idea of working and toxic dosage. Then you move on to various stages of human clinical trials and refine these treatment regimens. Once the drug makes it to market, you can continue to study its performance over the years and tweak usage guidelines as needed.
Latest Answers